Profil:
Celon Pharma SACelon Pharma to receive nearly PLN 66 mln from EU funds competition
Listed pharma company Celon Pharma will receive PLN 65.84 million (EUR 15.3 mln) in EU funding under the FENG.01.01IP.01-001/24 competition, Poland's Ministry of Development Fundfs and Regional Policy (MFiPR) announced on its website on European funding.
Celon Pharma will receive funding for the project 'Development of mRNA complex with lipid nanoparticles (LNP) with reduced immunogenicity for use in protein replacement therapy'.
The cost of the project was estimated at PLN 121.2 million (EUR 28.2 mln).
map/ ao/ nl/